Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome-Reference-Cited by-同舟云学术

Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome

Published:2015-04-03 Issue:4 Volume:21 Page:1037-1043
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Oshikawa Gaku,Yoshioka Kousuke,Takahashi Yukie,Shingai Naoki,Ikegawa Shuntaro,Kobayashil Takeshi,Doki Noriko,Kakihana Kazuhiko,Ohashi Kazuteru,Sakamaki Hisashi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-015-9933-8.pdf

Reference18 articles.

1. Gyurkocza B, Deeg HJ (2012) Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how? Blood Rev 26:247–254

2. Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R et al (2002) Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20:2429–2440

3. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A et al (2009) Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 10:223–232

4. Kim DY, Lee JH, Park YH, Kim SD, Choi Y, Lee SB et al (2012) Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome. Bone Marrow Transplant 47:374–379

5. Damaj G, Duhamel A, Robin M, Beguin Y, Michallet M, Mohty M et al (2012) Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies. J Clin Oncol 20:4533–4540

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

2. Pre-transplant therapy for patients with myelodysplastic syndromes: A systematic review and meta-analysis;Leukemia Research;2021-11

3. Comparison of Upfront Transplantation and Pretransplant Cytoreductive Therapy for Advanced Myelodysplastic Syndrome;Clinical Lymphoma Myeloma and Leukemia;2021-09

4. Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes;Clinical and Experimental Medicine;2021-04-17

5. Hypomethylating agents for patients with myelodysplastic syndromes prior to hematopoietic stem cell transplantation: a systematic review and meta-analysis;Annals of Hematology;2019-10-22